3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow CJM112: new trials by email Literature Review of CJM112 trials Research Report on CJM112
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess the Efficacy and Safety of CJM112 in Patients With Inadequately Controlled Severe Asthma CJM112, Placebo to CJM112 - Asthma | Phase 2 | Completed | Novartis Pharmaceuticals | 118 | 2017-11-06 | 2021-10-08 |
| Study of Efficacy and Safety of CJM112 in Patients With Moderate to Severe Inflammatory Acne CJM112, Placebo - Acne Vulgaris | Phase 2 | Completed | Novartis Pharmaceuticals | 52 | 2016-12-22 | 2022-07-12 |
| Efficacy, Safety, and Pharmacokinetics Study of CJM112 in Hidradenitis Suppurativa Patients CJM112, Placebo - Hidradenitis Suppurativa (Acne Inversa) | Phase 2 | Completed | Novartis Pharmaceuticals | 66 | 2015-04-13 | 2022-07-13 |
Acne Vulgaris (1) · Asthma (1) · Dyspnea (1) · Hidradenitis Suppurativa (1)
Germany (3) · United States (3) · Denmark (2) · Netherlands (2) · Argentina (1) · Belgium (1) · France (1) · Israel (1) · Slovakia (1) · Switzerland (1)
Christian Vestergaard (1) · Christos C Zouboulis (1) · E P Prens (1) · Falk G Bechara (1) · Gregor Jemec (1) · Jan Mekkes (1) · Lars French (1) · R Hunger (1) · Sylke Schneider-Burrus (1)